Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity

被引:107
作者
Kurono, Y
Yamamoto, M
Fujihashi, K
Kodama, S
Suzuki, M
Mogi, G
McGhee, JR
Kiyono, H
机构
[1] Kagoshima Univ, Fac Med, Dept Otolaryngol, Kagoshima 8908520, Japan
[2] Oita Med Univ, Dept Otolaryngol, Oita, Japan
[3] Osaka Univ, Dept Muscosal Immunol, Microbial Dis Res Inst, Osaka, Japan
[4] Univ Alabama Birmingham, Dept Oral Biol, Immunobiol Vaccine Ctr, Birmingham, AL 35294 USA
[5] Univ Alabama Birmingham, Dept Microbiol, Immunobiol Vaccine Ctr, Birmingham, AL 35294 USA
关键词
D O I
10.1086/314827
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To determine the efficacy of a mucosal vaccine against nontypeable Haemophilus influenzae (NTHi), mice were immunized nasally, orally, intratracheally, or intraperitoneally with NTHi antigen together with cholera toxin, Antigen-specific IgA antibody titers in nasal washes and the numbers of antigen-specific IgA-producing cells in nasal passages showed the greatest increases in mice immunized nasally. Cytokine analysis showed that interferon-gamma, interleukin (IL)-2, IL-5,IL-6, and IL-10 were induced by nasal immunization, suggesting that Th2- and Th1-type cells were generated. Furthermore, bacterial clearance of a homologous strain of NTHi from the nasal tract was significantly enhanced in the nasal immunization group. These findings suggest that nasal immunization is an effective vaccination regimen for the induction of antigen-specific mucosal immune responses, which reduce the colonization of NTHi in the nasal tract.
引用
收藏
页码:122 / 132
页数:11
相关论文
共 40 条
[11]   DISTRIBUTION OF IMMUNOCOMPETENT CELLS IN NORMAL NASAL-MUCOSA - COMPARISONS AMONG GERM-FREE, SPECIFIC PATHOGEN FREE, AND CONVENTIONAL MICE [J].
ICHIMIYA, I ;
KAWAUCHI, H ;
TANAKA, T ;
FUJIYOSHI, T ;
MOGI, G .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1991, 100 (08) :638-642
[12]   SUBCLASS-RESTRICTED IGG POLYCLONAL ANTIBODY-PRODUCTION IN MICE INJECTED WITH LIPID A-RICH LIPOPOLYSACCHARIDES [J].
IZUI, S ;
EISENBERG, RA ;
DIXON, FJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 153 (02) :324-338
[13]   OPTIMIZING ORAL VACCINES - INDUCTION OF SYSTEMIC AND MUCOSAL B-CELL AND ANTIBODY-RESPONSES TO TETANUS TOXOID BY USE OF CHOLERA-TOXIN AS AN ADJUVANT [J].
JACKSON, RJ ;
FUJIHASHI, K ;
XUAMANO, JC ;
KIYONO, H ;
ELSON, CO ;
MCGHEE, JR .
INFECTION AND IMMUNITY, 1993, 61 (10) :4272-4279
[14]  
KUPER CF, 1992, IMMUNOL TODAY, V13, P219
[15]  
KURONO Y, 1988, ARCH OTOLARYNGOL, V114, P1262
[16]   INHIBITION OF BACTERIAL ADHERENCE BY NASOPHARYNGEAL SECRETIONS [J].
KURONO, Y ;
SHIGEMI, H ;
SHIMAMURA, K ;
MOGI, G .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1991, 100 (06) :455-458
[17]   Effects of oral and systemic immunization on nasopharyngeal nontypeable Haemophilus influenzae in BALB/c mice [J].
Kurono, Y ;
Shigemi, H ;
Kodama, S ;
Mogi, G .
LARYNGOSCOPE, 1996, 106 (05) :614-618
[18]  
Kurono Y, 1996, ACTA OTO-LARYNGOL, P147
[19]   SYSTEMIC AND MUCOSAL IMMUNITY INDUCED BY BCG VECTOR EXPRESSING OUTER-SURFACE PROTEIN-A OF BORRELIA-BURGDORFERI [J].
LANGERMANN, S ;
PALASZYNSKI, S ;
SADZIENE, A ;
STOVER, CK ;
KOENIG, S .
NATURE, 1994, 372 (6506) :552-555
[20]  
LYCKE N, 1990, J IMMUNOL, V145, P3316